Rationale: Turner syndrome (TS) is a genetic disorder associated with partial or complete monosomy X abnormalities; some patients may have a higher risk of psychiatric symptoms. Catatonia is associated with a wide range of life-threatening complications with complex pathogenesis; However, It very rare for patients with TS to develop psychotic symptoms and eventually progress to catatonia. This case report describes the diagnostic and therapeutic course of catatonia-associated TS.
Patient Concerns: In this study, we report the case of a patient with TS who initially developed sudden hallucinations, delusions, and emotional instability, followed by catatonia.
Diagnoses: The patient was diagnosed with: unspecified catatonia; TS.
Interventions: Treatment included administering a combination of esazolam injections and olanzapine tablets, placing a gastric tube and urinary catheter, and providing nutritional support.
Outcomes: After treatment, the patient's hallucinations, delusions, and catatonia disappeared, with no residual sequelae, and social functioning returned to normal.
Lessons: For patients with TS who present with psychotic symptoms and catatonia, a comprehensive evaluation is necessary, and treatment with antipsychotics and benzodiazepines is effective.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10994426 | PMC |
| http://dx.doi.org/10.1097/MD.0000000000037730 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
MRI-based cortical gray/white matter contrast in young adults who endorse psychotic experiences or are at genetic risk for psychosis.
Psychiatry Res Neuroimaging
March 2025
PROMENTA Research Center, Department of Psychology, Pob 1094, Blindern, N-0317 Oslo, Forskningveien 3A, University of Oslo, Norway; Division of Mental Health and Substance Abuse, Diakonhjemmet Hospital, Oslo, Norway.
Research has reported group-level differences in cortical grey/white matter contrast (GWC) in individuals with psychotic disorders. However, no studies to date have explored GWC in individuals at elevated risk for psychosis. In this study, we examined brain microstructure differences between young adults with psychotic-like experiences or a high genetic risk for psychosis and unaffected individuals.
View Article and Find Full Text PDFCharacterising symptomatic substates in individuals on the psychosis continuum: a hidden Markov modelling approach.
Psychol Med
March 2025
Orygen, Parkville, VC, Australia.
Background: To improve early intervention and personalise treatment for individuals early on the psychosis continuum, a greater understanding of symptom dynamics is required. We address this by identifying and evaluating the movement between empirically derived attenuated psychotic symptomatic substates-clusters of symptoms that occur within individuals over time.
Methods: Data came from a 90-day daily diary study evaluating attenuated psychotic and affective symptoms.
Purpose Of Review: This review examines the literature associating cannabis with schizophrenia, glutamate dysregulation in schizophrenia, and cannabis involvement in glutamate pathways. Cannabis use is widespread among adolescents world-wide and is sold legally in many countries for recreational use in a variety of forms. Most people use it without lasting effects, but a portion of individuals have negative reactions that manifest in acute psychotic symptoms, and in some, symptoms continue even after the use of cannabis has ceased.
View Article and Find Full Text PDFAlteration in network centrality of psychopathology symptoms in public bus driver between the COVID-19 control policies unbundling.
BMC Psychiatry
March 2025
Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Background: Bus drivers face complex work challenges and high infection risks, particularly heightened during the COVID-19 pandemic, which significantly affects their mental health. This study used network analysis to conduct a longitudinal follow-up of the psychological symptom network of bus drivers, utilizing the Symptom Checklist-90-Revised (SCL-90-R).
Design: A repeated-measures self-controlled observational design was used to survey 1,600 intercity bus drivers in a city in southern Anhui, China, in September 2022 and January 2023, respectively, and participant data were analyzed using regularized partial correlation network analysis.
Impact of long-acting injectable antipsychotics in early psychosis: An umbrella review.
Schizophr Res
March 2025
Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team pharmacoepidemiology, UMR 1219, F-33000 Bordeaux, France. Electronic address:
Objectives: There is still no consensus regarding the indications of long-acting injectable antipsychotics (LAIs) in early psychosis (EP). This umbrella review synthesizes findings from systematic reviews and meta-analyses on the risk-benefit balance of LAIs in EP.
Methods: Eligible systematic reviews and meta-analyses on LAIs in EP were identified by a MEDLINE search from inception until June 2024.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!